Tag: cardiomyopathy
Bristol Myers Squibb launches Kopozgo in India for treatment of symptomatic...
Kopozgo is the first and only cardiac myosin inhibitor that specifically targets the underlying pathophysiology of obstructive HCM in India
Study identifies genetic risk factors for heart failure
A gene called β-MYH7 is one of the major genes implicated in cardiac diseases globally